Company overview
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing BTMD with another company.
| Daily close (USD) | $1.17 |
| Market capitalization (USD) | $42,035,137.56 |
| Price / earnings (TTM) | 7.18 |
| Price / book | Not reported |
No matching rows. Clear the filter to see all records.
Read BTMD's valuation metrics
Company size
Biote Corp. Class A Common Stock's recorded market capitalization is $42,035,137.56. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
BTMD's recorded P/E is 7.18: about $7.18 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.
Research Biote Corp. Class A Common Stock with Aurora
Use the snapshot above to ask a specific question about BTMD. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow BTMD's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.